EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Neuroprotection of Artesunate and Tetramethylpyrazine in Ischemic Stroke, Mechanisms of Blood–Brain Barrier Preservation

Yan Liang, Shuoqiu Deng, Yu Li, Shuiqing Qu, Chengcheng Liu, Luqi Wang, Lina Chen, Tuo Liu, Yujie Li iD

International Journal of Molecular Sciences · 18.08.2025 · 26 (16) · 7979

DOI: 10.3390/ijms26167979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2025. Verfasst von Yan Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Qualty Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical …. Hauptthemen laut MEDLINE: Pyrazines, Blood-Brain Barrier, Artesunate, Ischemic Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Project of Chinese Academy of Traditional Chinese Medicine, National Natural Science Foundation of China, Scientific and technological innovation project of China Academy of Chinese Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artesunate (AS) and tetramethylpyrazine (TMP) have been proven to have therapeutic potential in ischemic stroke. Nevertheless, their synergistic treatment mechanisms and effectiveness remain unclear. A rat MCAO model was induced, and AS, combined with TMP, was administered intranasally to rats once a day for 3 days. The neurological severity scores, TTC staining, and H&E staining were implemented to analyze tissue injuries. Evans blue staining and immunohistochemistry of ZO-1, occludin, MMP-9, and TIMP-1 were implemented to evaluate the integrity of the blood–brain barrier (BBB). ELISA was used to detect the expression levels of inflammatory factors TNF-α and IL-10. TUNEL staining and the protein expression of Bax and Bcl-2 were used to evaluate the apoptosis of brain tissue cells. The core targets were predicted by network pharmacology and verified by the OGD/R cell model and siRNA in vitro. Results showed that nasal administration of AS and TMP significantly ameliorated ischemic-stroke-induced neurological dysfunction, BBB disruption, and cortical neuronal apoptosis. The protective mechanisms mainly included adjusting the expression and ratio of tight junction proteins TIMP-1 and MMP-9 in brain tissue, regulating the HIF-1α-VEGF pathway, and anti-inflammatory effects. This study provides experimental support for the further development and application of AS and TMP nasal combinations and provides the foundation for expanding the practical-application value of artemisinin and its derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesBlood-Brain BarrierArtesunateIschemic StrokeNeuroprotective AgentsAnimalsRatsMaleApoptosisRats, Sprague-DawleyMatrix Metalloproteinase 9Drug SynergismDisease Models, AnimalInfarction, Middle Cerebral ArteryTissue Inhibitor of Metalloproteinase-1Neuroprotection

Stichwörter der Autor:innen

BBBMMP9TIMP1artesunateischemic stroketetramethylpyrazine

Substanzen

tetramethylpyrazinePyrazinesArtesunateNeuroprotective AgentsMatrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-1

Autor:innen und Institutionen

  • State Key Laboratory for Qualty Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Dongcheng District, Beijing 100700, China.
  • Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.

ORCID-Profile: Yujie Li

Förderung

  • Science and Technology Innovation Project of Chinese Academy of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • Scientific and technological innovation project of China Academy of Chinese Medical Sciences
  • Fundamental Research Funds for the Central public welfare research institutes
  • Scientific and technological innovation project of China Academy of Chinese Medical Science

Zitieren

APA

Liang, Y., Deng, S., Li, Y., Qu, S., Liu, C., Wang, L., Chen, L., Liu, T., & Li, Y. (2025). Synergistic Neuroprotection of Artesunate and Tetramethylpyrazine in Ischemic Stroke, Mechanisms of Blood–Brain Barrier Preservation. International Journal of Molecular Sciences, 26(16), 7979. https://doi.org/10.3390/ijms26167979

Vancouver

Liang Y, Deng S, Li Y, Qu S, Liu C, Wang L, et al. Synergistic Neuroprotection of Artesunate and Tetramethylpyrazine in Ischemic Stroke, Mechanisms of Blood–Brain Barrier Preservation. International Journal of Molecular Sciences. 2025;26(16):7979. doi:10.3390/ijms26167979

BibTeX
@article{Liang2025,
  author = {Liang, Yan and Deng, Shuoqiu and Li, Yu and Qu, Shuiqing and Liu, Chengcheng and Wang, Luqi and Chen, Lina and Liu, Tuo and Li, Yujie},
  title = {Synergistic Neuroprotection of Artesunate and Tetramethylpyrazine in Ischemic Stroke, Mechanisms of Blood–Brain Barrier Preservation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {16},
  pages = {7979},
  doi = {10.3390/ijms26167979}
}
Kostenlos starten →